Clinical Trials Search

Title Intervention NCT IDsort descending Sponsor Status
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer Bio-Specimen Collection NCT03260842 Stanford University Recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Active, not recruiting
Lifestyle Change for Better Health Dietary Intervention, Physical Activity Intervention NCT03286699 University of Pittsburgh Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Active, not recruiting
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine NCT03300817 National Cancer Institute (NCI) Active, not recruiting
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients Biospecimen Collection, Laboratory Biomarker Analysis, Magnetic Resonance Imaging NCT03303846 City of Hope Medical Center Recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Endoxifen Hydrochloride, Placebo Administration, Questionnaire Administration NCT03317405 National Cancer Institute (NCI) Active, not recruiting
Dexamethasone in Controlling Dyspnea in Patients With Cancer Dexamethasone, Placebo, Questionnaire Administration NCT03367156 M.D. Anderson Cancer Center Active, not recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or... Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment NCT03367572 University of Rochester NCORP Research Base Recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting

Pages